Clinical outcomes and tumor laterality analysis after stereotactic body radiotherapy for peripheral pulmonary lesions: a retrospective single-institution study
Stereotactic body radiotherapy (SBRT/SABR) is a curative treatment for early-stage lung cancer in patients unsuitable for surgery. While tumor laterality is routinely considered in surgical decision-making, its relevance to outcomes after SBRT remains unclear. This study evaluated clinical outcomes after SBRT and...